Login / Signup

Risk of cutaneous herpes zoster in patients with spondyloarthritis treated with conventional and biologic disease-modifying antirheumatic drugs.

Sabrina Ching Tung WongIris Wai Sum LiAlexandra Hoi Yan NgChak Sing LauHo Yin Chung
Published in: International journal of rheumatic diseases (2019)
Risk of cutaneous HZ in SpA was not lower than in RA. Methotrexate and infliximab were associated with cutaneous HZ in SpA.
Keyphrases
  • rheumatoid arthritis
  • disease activity
  • ankylosing spondylitis
  • rheumatoid arthritis patients
  • systemic lupus erythematosus
  • low dose
  • interstitial lung disease
  • ulcerative colitis